Macomics is an immuno-oncology company. Founded in 2020, Macomics is backed by investors that include Scottish Investment Bank and Epidarex Capital and is headquartered in Edinburgh.
FOUNDED:
2020
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.